Population Pharmacokinetics of C1 Esterase Inhibitor Used to Treat Patients with Acute Hereditary Angioedema Attacks in a Multicenter, Randomized, Placebo-controlled Study (I.M.P.A.C.T.1)
C1 esterase inhibitor (C1-INH) replacement therapy is the gold standard for treating acute attacks in hereditary angioedema (HAE).
Gespeichert in:
| Veröffentlicht in: | Journal of allergy and clinical immunology 2010-02, Vol.125 (2), p.AB164-AB164 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | AB164 |
|---|---|
| container_issue | 2 |
| container_start_page | AB164 |
| container_title | Journal of allergy and clinical immunology |
| container_volume | 125 |
| creator | Ritchie, B Levy, R Wasserman, R Bewtra, A Hurewitz, D Obtulowicz, K Reshef, A Moldovan, D Shirov, T Grivcheva-Panovska, V Bernstein, J Kiessling, P Schindel, F Craig, T |
| description | C1 esterase inhibitor (C1-INH) replacement therapy is the gold standard for treating acute attacks in hereditary angioedema (HAE). |
| doi_str_mv | 10.1016/j.jaci.2009.12.644 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1504883093</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091674909024427</els_id><sourcerecordid>3239904371</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1793-f9e7a4794bf433b76027040802f011002d8de7dcce37913a5b4aad3b47144f203</originalsourceid><addsrcrecordid>eNp9kt-K1DAUxosoOK6-gFcBbxS2MUkzTQsilGH_DOxicWevQ5qcOpnpNLNJqoyv5suZMoLghVfhkPM73-H7Tpa9pQRTQsuPO7xT2mJGSI0pwyXnz7IFJbXIy4otn2eL9EHzUvD6ZfYqhB1JdVHVi-xX647ToKJ1I2q3yh-Udns7QrQ6INejFUVXIYJXAdB63NrORufRYwCDokMbDyqiNuEwxoB-2LhFjZ4ioFvwYGxU_oSa8Zt1YOCgUBOj0vuA7IgUup-GpJJA8JfoqxqNO9ifYC5ROygNncu1G6N3w5C0HuJkTuj9Gt_jFjd4hTeYfnidvejVEODNn_cie7y-2qxu87svN-tVc5drKuoi72sQiouadz0vik6UhAnCSUVYTyglhJnKgDBaQyFqWqhlx5UyRccF5bxnpLjI3p3nHr17miBEuXOTH5OkpEvCq6pIZqYudu7S3oXgoZdHbw_JAEmJnEOSOzmHJOeQJGUyhZSgT2cI0v7fLXgZdPJSJ-886CiNs__HP_-D68GOVqthDycIf9eUgUkiH-YrmI-A1IRxzkTxG5hkr60</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1504883093</pqid></control><display><type>article</type><title>Population Pharmacokinetics of C1 Esterase Inhibitor Used to Treat Patients with Acute Hereditary Angioedema Attacks in a Multicenter, Randomized, Placebo-controlled Study (I.M.P.A.C.T.1)</title><source>Access via ScienceDirect (Elsevier)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Ritchie, B ; Levy, R ; Wasserman, R ; Bewtra, A ; Hurewitz, D ; Obtulowicz, K ; Reshef, A ; Moldovan, D ; Shirov, T ; Grivcheva-Panovska, V ; Bernstein, J ; Kiessling, P ; Schindel, F ; Craig, T</creator><creatorcontrib>Ritchie, B ; Levy, R ; Wasserman, R ; Bewtra, A ; Hurewitz, D ; Obtulowicz, K ; Reshef, A ; Moldovan, D ; Shirov, T ; Grivcheva-Panovska, V ; Bernstein, J ; Kiessling, P ; Schindel, F ; Craig, T</creatorcontrib><description>C1 esterase inhibitor (C1-INH) replacement therapy is the gold standard for treating acute attacks in hereditary angioedema (HAE).</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2009.12.644</identifier><language>eng</language><publisher>St. Louis: Mosby, Inc</publisher><subject>Allergy and Immunology ; Confidence intervals ; Medical treatment ; Population</subject><ispartof>Journal of allergy and clinical immunology, 2010-02, Vol.125 (2), p.AB164-AB164</ispartof><rights>American Academy of Allergy, Asthma & Immunology</rights><rights>2010 American Academy of Allergy, Asthma & Immunology</rights><rights>Copyright Elsevier Limited Feb 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jaci.2009.12.644$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids></links><search><creatorcontrib>Ritchie, B</creatorcontrib><creatorcontrib>Levy, R</creatorcontrib><creatorcontrib>Wasserman, R</creatorcontrib><creatorcontrib>Bewtra, A</creatorcontrib><creatorcontrib>Hurewitz, D</creatorcontrib><creatorcontrib>Obtulowicz, K</creatorcontrib><creatorcontrib>Reshef, A</creatorcontrib><creatorcontrib>Moldovan, D</creatorcontrib><creatorcontrib>Shirov, T</creatorcontrib><creatorcontrib>Grivcheva-Panovska, V</creatorcontrib><creatorcontrib>Bernstein, J</creatorcontrib><creatorcontrib>Kiessling, P</creatorcontrib><creatorcontrib>Schindel, F</creatorcontrib><creatorcontrib>Craig, T</creatorcontrib><title>Population Pharmacokinetics of C1 Esterase Inhibitor Used to Treat Patients with Acute Hereditary Angioedema Attacks in a Multicenter, Randomized, Placebo-controlled Study (I.M.P.A.C.T.1)</title><title>Journal of allergy and clinical immunology</title><description>C1 esterase inhibitor (C1-INH) replacement therapy is the gold standard for treating acute attacks in hereditary angioedema (HAE).</description><subject>Allergy and Immunology</subject><subject>Confidence intervals</subject><subject>Medical treatment</subject><subject>Population</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNp9kt-K1DAUxosoOK6-gFcBbxS2MUkzTQsilGH_DOxicWevQ5qcOpnpNLNJqoyv5suZMoLghVfhkPM73-H7Tpa9pQRTQsuPO7xT2mJGSI0pwyXnz7IFJbXIy4otn2eL9EHzUvD6ZfYqhB1JdVHVi-xX647ToKJ1I2q3yh-Udns7QrQ6INejFUVXIYJXAdB63NrORufRYwCDokMbDyqiNuEwxoB-2LhFjZ4ioFvwYGxU_oSa8Zt1YOCgUBOj0vuA7IgUup-GpJJA8JfoqxqNO9ifYC5ROygNncu1G6N3w5C0HuJkTuj9Gt_jFjd4hTeYfnidvejVEODNn_cie7y-2qxu87svN-tVc5drKuoi72sQiouadz0vik6UhAnCSUVYTyglhJnKgDBaQyFqWqhlx5UyRccF5bxnpLjI3p3nHr17miBEuXOTH5OkpEvCq6pIZqYudu7S3oXgoZdHbw_JAEmJnEOSOzmHJOeQJGUyhZSgT2cI0v7fLXgZdPJSJ-886CiNs__HP_-D68GOVqthDycIf9eUgUkiH-YrmI-A1IRxzkTxG5hkr60</recordid><startdate>20100201</startdate><enddate>20100201</enddate><creator>Ritchie, B</creator><creator>Levy, R</creator><creator>Wasserman, R</creator><creator>Bewtra, A</creator><creator>Hurewitz, D</creator><creator>Obtulowicz, K</creator><creator>Reshef, A</creator><creator>Moldovan, D</creator><creator>Shirov, T</creator><creator>Grivcheva-Panovska, V</creator><creator>Bernstein, J</creator><creator>Kiessling, P</creator><creator>Schindel, F</creator><creator>Craig, T</creator><general>Mosby, Inc</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7SS</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20100201</creationdate><title>Population Pharmacokinetics of C1 Esterase Inhibitor Used to Treat Patients with Acute Hereditary Angioedema Attacks in a Multicenter, Randomized, Placebo-controlled Study (I.M.P.A.C.T.1)</title><author>Ritchie, B ; Levy, R ; Wasserman, R ; Bewtra, A ; Hurewitz, D ; Obtulowicz, K ; Reshef, A ; Moldovan, D ; Shirov, T ; Grivcheva-Panovska, V ; Bernstein, J ; Kiessling, P ; Schindel, F ; Craig, T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1793-f9e7a4794bf433b76027040802f011002d8de7dcce37913a5b4aad3b47144f203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Allergy and Immunology</topic><topic>Confidence intervals</topic><topic>Medical treatment</topic><topic>Population</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ritchie, B</creatorcontrib><creatorcontrib>Levy, R</creatorcontrib><creatorcontrib>Wasserman, R</creatorcontrib><creatorcontrib>Bewtra, A</creatorcontrib><creatorcontrib>Hurewitz, D</creatorcontrib><creatorcontrib>Obtulowicz, K</creatorcontrib><creatorcontrib>Reshef, A</creatorcontrib><creatorcontrib>Moldovan, D</creatorcontrib><creatorcontrib>Shirov, T</creatorcontrib><creatorcontrib>Grivcheva-Panovska, V</creatorcontrib><creatorcontrib>Bernstein, J</creatorcontrib><creatorcontrib>Kiessling, P</creatorcontrib><creatorcontrib>Schindel, F</creatorcontrib><creatorcontrib>Craig, T</creatorcontrib><collection>CrossRef</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ritchie, B</au><au>Levy, R</au><au>Wasserman, R</au><au>Bewtra, A</au><au>Hurewitz, D</au><au>Obtulowicz, K</au><au>Reshef, A</au><au>Moldovan, D</au><au>Shirov, T</au><au>Grivcheva-Panovska, V</au><au>Bernstein, J</au><au>Kiessling, P</au><au>Schindel, F</au><au>Craig, T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Population Pharmacokinetics of C1 Esterase Inhibitor Used to Treat Patients with Acute Hereditary Angioedema Attacks in a Multicenter, Randomized, Placebo-controlled Study (I.M.P.A.C.T.1)</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><date>2010-02-01</date><risdate>2010</risdate><volume>125</volume><issue>2</issue><spage>AB164</spage><epage>AB164</epage><pages>AB164-AB164</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><abstract>C1 esterase inhibitor (C1-INH) replacement therapy is the gold standard for treating acute attacks in hereditary angioedema (HAE).</abstract><cop>St. Louis</cop><pub>Mosby, Inc</pub><doi>10.1016/j.jaci.2009.12.644</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0091-6749 |
| ispartof | Journal of allergy and clinical immunology, 2010-02, Vol.125 (2), p.AB164-AB164 |
| issn | 0091-6749 1097-6825 |
| language | eng |
| recordid | cdi_proquest_journals_1504883093 |
| source | Access via ScienceDirect (Elsevier); EZB-FREE-00999 freely available EZB journals |
| subjects | Allergy and Immunology Confidence intervals Medical treatment Population |
| title | Population Pharmacokinetics of C1 Esterase Inhibitor Used to Treat Patients with Acute Hereditary Angioedema Attacks in a Multicenter, Randomized, Placebo-controlled Study (I.M.P.A.C.T.1) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T14%3A45%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Population%20Pharmacokinetics%20of%20C1%20Esterase%20Inhibitor%20Used%20to%20Treat%20Patients%20with%20Acute%20Hereditary%20Angioedema%20Attacks%20in%20a%20Multicenter,%20Randomized,%20Placebo-controlled%20Study%20(I.M.P.A.C.T.1)&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Ritchie,%20B&rft.date=2010-02-01&rft.volume=125&rft.issue=2&rft.spage=AB164&rft.epage=AB164&rft.pages=AB164-AB164&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/j.jaci.2009.12.644&rft_dat=%3Cproquest_cross%3E3239904371%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1504883093&rft_id=info:pmid/&rft_els_id=S0091674909024427&rfr_iscdi=true |